NAMS (NewAmsterdam Pharma) Rega marang bathi mangsa ngarep

Lambang korporat lan logo NewAmsterdam Pharma N.V. (NAMS)

NewAmsterdam Pharma (NAMS) minimizes costs by outsourcing production and testing to external partners. Supply stability is guaranteed through the diversification of regional supply channels. The company is currently focused on capturing the cardiometabolic market via the launch of its flagship drug. The issuer's expected P/E helps assess the business value relative to future earnings, while 0.00 captures the current state of the parameter on the chart.

NAMS - Rasio prakiraan rega marang bathi NewAmsterdam Pharma Company ing rentang 21.06.2023 - 16.11.2026

Rincian analitis perusahaan NewAmsterdam Pharma

Analisis umum perusahaan:NAMS newamsterdampharma.com
Produk merek NewAmsterdam Pharma Corp

For a comparative asset analysis, the investor utilizes this indicator as a measure of the market value of one unit of expected earnings, which allows for an assessment of the premium paid for future growth. The expected P/E multiple for NewAmsterdam Pharma (NAMS) reflects the consensus earnings forecast, which in the case of NewAmsterdam Pharma (NAMS) depends directly on the success of partnership developments in metabolic therapy and the prospects of acquisition by industry behemoths.

Pesaing NewAmsterdam Pharma (NAMS)

Prakiraan rega marang bathi ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep corcept.com CORT|RYTM - Prakiraan rega marang bathi|Akero Corp - Pangali Forward P/E|Rasio prakiraan rega marang bathi Metsera Corp|MLTX (MoonLake) - Prakiraan rega marang bathi|CRNX: Rasio kapitalisasi marang bathi mangsa ngarep|SLNO (Soleno Therapeutics Corp) - Pangali Forward P/E|Pangali Forward P/E Amicus Therapeutics|Pangali Forward P/E ETNB|Rega marang bathi mangsa ngarep AGIO (Agios)|Rega marang bathi mangsa ngarep structuretx.com GPCR|MiMedx Corp (MDXG) - Rasio prakiraan rega marang bathi|RZLT - Rega marang bathi mangsa ngarep|LXRX: Rega marang bathi mangsa ngarep|MBX Biosciences, Inc. (MBX) - Rega marang bathi mangsa ngarep|ALT - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep bioagelabs.com (BIOA)|Prakiraan rega marang bathi Biomea Fusion, Inc. BMEA|Rega marang bathi mangsa ngarep Quince QNCX|GUTS (Fractyl Health Inc.) - Rasio rega marang bathi sing dikarepake|VTVT: Prakiraan rega marang bathi|Pangali forward rega marang bathi agapeatpgroup.com (ATPC)|PLUR (Pluri) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep SYBX|Rega marang bathi mangsa ngarep Lipocine Corporation|matinasbiopharma.com (MTNB) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SPRB|Prakiraan rega marang bathi Galecto, Inc. GLTO|Rega marang bathi mangsa ngarep Carmell Corporation CTCX|Pangali mangsa ngarep rega marang bathi LUMO|ONVO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RDUS (Radius Recycling Inc.)